This inventor holds 1 USPTO granted patent. Top assignees: Unversität Zürich, Wayne State University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022
Title: Innovations of Parasuraman Rajasekaran
Introduction
Parasuraman Rajasekaran is an accomplished inventor based in Detroit, MI (US). He has made significant contributions to the field of antibacterial drugs, particularly through his innovative work on apramycin derivatives. His research focuses on enhancing the efficacy of aminoglycoside antibacterial drugs, which are crucial in combating bacterial infections.
Latest Patents
Rajasekaran holds a patent for his invention related to apramycin derivatives. This invention pertains to derivatives of apramycin-based aminoglycoside antibacterial drugs that are modified in positions C5 and/or C6 and O5 and/or O6. These modifications provide favorable properties, including increased selectivity and retention of activity in the presence of resistance determinants of the AAC(3) class. The compounds are particularly useful in the therapy of bacterial infections caused by pathogens with resistance determinants, especially AAC(3)-IV.
Career Highlights
Throughout his career, Rajasekaran has worked with notable institutions, including Wayne State University and Universität Zürich. His work has been instrumental in advancing the understanding and treatment of bacterial infections, showcasing his dedication to medical innovation.
Collaborations
Rajasekaran has collaborated with esteemed colleagues such as Erik C Bottger and Sven N Hobbie. These partnerships have further enriched his research and contributed to the development of effective antibacterial therapies.
Conclusion
Parasuraman Rajasekaran's contributions to the field of antibacterial drugs through his innovative patents and collaborations highlight his role as a significant inventor in the medical research community. His work continues to impact the treatment of bacterial infections, demonstrating the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile